about
Severe pre-eclampsia and hypertensive crisesHigh rates of tuberculosis in end-stage renal failure: the impact of international migrationUrinary proteomic profiles distinguish between active and inactive lupus nephritis.A patient with suspected miscarriage is found to have hypertension, renal failure, and thrombocytopenia: case outcome.Goodpasture's disease.Genetic loci influencing kidney function and chronic kidney diseaseNecrotizing and crescentic glomerulonephritis presenting with preserved renal function in patients with underlying multisystem autoimmune disease: a retrospective case series.In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DMJoint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.Seasonal relapsing minimal change disease: a novel strategy for avoiding long-term immunosuppressionPregnancy in pancreas-kidney transplant recipients: report of three cases and review of the literature.European consensus statement on the terminology used in the management of lupus glomerulonephritis.Lupus nephritis: where are we now?Pre-pregnancy counseling for women with chronic kidney disease.Minimising steroids in lupus nephritis--will B cell depletion pave the way?Renoprotective strategies in lupus nephritis: beyond immunosuppression.Problems in the physiology of class I and class II MHC molecules, and of CD45.Lupus Nephritis and Pregnancy: Concerns and Management.Pregnancy in chronic kidney disease and kidney transplantation.A Multicenter Cohort Study of Histologic Findings and Long-Term Outcomes of Kidney Disease in Women Who Have Been Pregnant.Hyper-reactivity of mouse CD45RA- T cells.The endogenous pathway of MHC class II antigen presentation.Antigen presentation by T cells inhibits IL-2 production and induces IL-4 release due to altered cognate signals.Positive antineutrophil cytoplasmic antibody serology in patients with lupus nephritis is associated with distinct histopathologic features on renal biopsy.Eculizumab as rescue therapy in severe resistant lupus nephritis.Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids.Distal renal tubular acidosis in association with HIV infection and AIDS.Haplotype structure of TNFRSF5-TNFSF5 (CD40-CD40L) and association analysis in systemic lupus erythematosus.High incidence of end-stage renal disease in Indo-Asians in the UK.A patient with suspected miscarriage is found to have hypertension, renal failure, and thrombocytopenia: case presentation.A patient with suspected miscarriage is found to have hypertension, renal failure, and thrombocytopenia: case progression.Hydroxycloroquine blood concentration in lupus nephritis: a determinant of disease outcome?Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease.ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap.Lack of awareness of kidney complications despite familiarity with diabetes: a multi-ethnic qualitative study.Can we withdraw immunosuppressants in patients with lupus nephritis in remission? An expert debate.Mycophenolate mofetil therapy in immunoglobulin A nephropathy: histological changes after treatment.The exaggerated inflammatory response in Behçet's syndrome: identification of dysfunctional post-transcriptional regulation of the IFN-γ/CXCL10 IP-10 pathway.Glomerular Disease in Women.
P50
Q28296949-0238A1F0-5C0C-4B17-BE74-B5DF82E5DDEEQ28366767-F339EDEB-40FB-4EDE-8355-4E7E4B1AEB6DQ33260649-B48210CE-CA4F-4E70-AAF0-B090F51F63E4Q33376018-E1267B18-8FBA-40AF-A3E2-8CD8C8CC0721Q34092200-B6BEE89C-6014-41B5-950D-11D94C3E78DEQ34109552-B1441A85-645C-4B51-9499-86F7A9A7C4CEQ35767701-846F1EF7-E470-43EF-8B60-2F6223DB02F5Q36158655-82CACEB2-6661-418C-83F1-5FAF2EA523B8Q36302245-73EABB41-4D81-41E3-92BC-2CE91AD8C263Q36350083-853DC72B-3C13-4AE7-8C36-36E2236C49B0Q37186145-E60FC3FF-88C2-4CD7-9A9F-C2C6544D04CBQ37391863-452623D9-276B-4034-A997-37044032E228Q37715686-8120A28E-5648-4C54-A5C1-2ECE782A7F17Q38014006-C99D11AF-16C7-44BC-91C3-88154AE7A251Q38095864-A97BFF3D-045F-4CCB-9C1A-6AFEB91EDA2BQ38149854-39E2669D-9F48-474F-A8B7-4498317D8157Q38263065-768177F8-4034-42E2-B4B8-908D6E71A21BQ38657186-8539A4AA-4D3E-4526-A3BB-1333D0E3224AQ39139559-504F439D-1B39-4737-850A-6E5DB3F7AF8FQ40430668-A391CB56-59DA-46D6-B6A4-91F6B467D3C3Q40845459-4AFDC1C0-C37D-4C15-A0DB-04650DF74504Q41168212-E5FB1A70-D6EE-4721-9CB4-6F6E850BD424Q41205926-F629B260-362D-4DBC-B472-3210606C2C76Q42650330-249DD5C1-0798-4E80-8A34-61B0F9BEBDCCQ43177789-596CA7EC-29D3-4F33-8CF1-71B7878EE8C7Q43472878-E35146EC-9EF6-4E6C-92FA-8A06931C8DC5Q43699030-F91FDFCE-2B5C-4C9F-B70C-BA03EB61C5F5Q43912390-D8C52805-4B99-4FAC-A203-417DEA100E35Q44688804-3BDE6A33-F80A-4432-8990-A7369F82F95FQ44995050-2DB5C65D-8771-43EE-B978-DA20F24F4E85Q46469880-B73598E9-4A48-4584-9A3C-4218528FB574Q46530824-9672E5B1-46A4-4AEF-948C-4FAE108A2FC5Q47396929-F859D528-FA10-4497-B123-71BF398C9989Q48872855-ACC53516-ADF3-418F-8D70-7A3FCDE20917Q49215238-ED166AC1-9FFA-4FB2-83E2-33462A2577CDQ50117159-CFC64E3F-F0CF-4658-A5FE-66BDA8997C21Q50133627-C6B6E861-5FFA-4A04-96AE-1815134D9BD0Q50740436-72637103-D301-48E8-A0BD-37C86E9CAC71Q52942759-82BB8CF2-63B8-411D-B044-676CB7BCE6BAQ54994281-0BD90E93-3926-49FD-927F-EF28306217C6
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
L Lightstone
@ast
L Lightstone
@en
L Lightstone
@es
L Lightstone
@nl
type
label
L Lightstone
@ast
L Lightstone
@en
L Lightstone
@es
L Lightstone
@nl
altLabel
Liz Lightstone
@en
prefLabel
L Lightstone
@ast
L Lightstone
@en
L Lightstone
@es
L Lightstone
@nl
P1053
M-4331-2014
P106
P1153
7004157554
P31
P496
0000-0002-4603-4076